https://www.selleckchem.com/pr....oducts/act001-dmamcl
This commentary uses the negative results of the PAVE (Paclitaxel-coated Balloons and Angioplasty of Arteriovenous Fistulas) study to (i) discuss the role of drug-coated balloons in the armamentarium of therapies for dialysis vascular access stenosis and (ii) suggest a more patient centered, individualized, and precision medicine-based approach for the future care of patients with dialysis vascular access dysfunction.Chronic active T cell-mediated rejection, demonstrated by the presence of inflammation in areas of fibrosis, is ass
Like
Comment
Share
